-transparent.png){kind=logo}
Thirty patients with advanced breast cancer, not pretreated with chemotherapy, received a polychemotherapy regimen containing mitoxantrone, fluorouracil and cyclophosphamide at the dose of 10 mg/m2, 500 mg/m2 and 500 mg/m2 i.v. respectively every 28 days. Out of 25 patients evaluable for response 9 patients achieved a partial remission (36%) for a median duration of 20.5 weeks. The main side effects were leukopenia (grade 3-4 in 70%) and nausea-vomiting (grade 3-4 in 27%). Alopecia was present only in 5 patients (17%). Three patients demonstrated instrumental signs of cardiotoxicity without clinical symptoms.
Related Publications
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
February 2005,
Onkologie,
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
September 1984,
Seminars in oncology,
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
January 1985,
Investigational new drugs,
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
April 1993,
International journal of oncology,
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
September 1986,
Gan to kagaku ryoho. Cancer & chemotherapy,
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
December 1989,
The Netherlands journal of medicine,
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
September 1984,
Seminars in oncology,
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
December 1983,
Cancer treatment reviews,
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
April 1991,
Journal of chemotherapy (Florence, Italy),
A Martoni, and
P Rani, and
L Ercolino, and
N Canova, and
F Pannuti
October 1984,
Cancer treatment reports,
